THIS SITE IS NOT INTENDED OR DESIGNED FOR REPORTING OF ADVERSE EVENTS
Roche is required to document reports of adverse events, both for comprehensive safety monitoring of its products and also to fulfill reporting requirements to Regulatory Authorities. It allows continued monitoring of the benefit/risk balance of the medicinal product.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Roche Products Ltd. Please contact Roche Drug Safety Centre by emailing firstname.lastname@example.org or calling +44 (0)1707 367554.
Please provide the brand name and batch number, where possible. It is very important that safety surveillance is carried out on a brand/product specific basis to ensure the information collected is accurate.
▼ Additional monitoring:
Medicinal products which have an inverted black triangle next to their name in materials such as the Patient Information Leaflet are subject to additional monitoring. Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.
Date of preparation: September 2021